Lataa...
Gemcitabine enhances antitumor efficacy of recombinant lipoimmunogen-based immunotherapy
Although immunotherapy is an attractive approach for cancer treatment, increasing evidence has shown that the combination of immunotherapy with other treatment modalities may improve the outcome of advanced malignancy. We combined the anticancer drug gemcitabine (Gem) with recombinant lipoprotein-ba...
Tallennettuna:
| Julkaisussa: | Oncoimmunology |
|---|---|
| Päätekijät: | , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Taylor & Francis
2015
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4839335/ https://ncbi.nlm.nih.gov/pubmed/27141356 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2015.1095433 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|